tiprankstipranks
Advertisement
Advertisement
Purple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
PremiumCompany AnnouncementsPurple Biotech Taps Converge Bio’s AI to Turbocharge Tri-Specific Antibody Platform
2M ago
Purple Biotech announces collaboration with Converge Bio
Premium
The Fly
Purple Biotech announces collaboration with Converge Bio
2M ago
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
Premium
TipRanks Newswire
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)
2M ago
Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright
PremiumThe FlyPurple Biotech price target lowered to $30 from $34 at H.C. Wainwright
3M ago
Purple Biotech Posts 2025 Loss, Doubles Down on CAPTN-3 Immunotherapy Platform
Premium
Company Announcements
Purple Biotech Posts 2025 Loss, Doubles Down on CAPTN-3 Immunotherapy Platform
3M ago
Purple Biotech CEO Gil Efron to step down in August
Premium
The Fly
Purple Biotech CEO Gil Efron to step down in August
3M ago
Purple Biotech to Implement ADS Ratio Change to Regain Nasdaq Bid-Price Compliance
PremiumCompany AnnouncementsPurple Biotech to Implement ADS Ratio Change to Regain Nasdaq Bid-Price Compliance
3M ago
PPBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PPBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Purple Biotech Unveils January 2026 Corporate Update, Mapping 2026 Catalysts for CAPTN-3 and Oncology Pipeline
Premium
Company Announcements
Purple Biotech Unveils January 2026 Corporate Update, Mapping 2026 Catalysts for CAPTN-3 and Oncology Pipeline
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100